Our Work with the US Healthcare and Nonprofit Communities
Reporting on Our Relationships
No physician, researcher or healthcare company works in a silo. We need each other—and many others—to help move healthcare forward.
For our part, we work with members of the healthcare community—treating physicians, clinical researchers, patients, professional associations and advocacy groups, etc.— who are close to patients and understand both diseases and treatments. This collaboration is vital to our mission to help people do more, feel better and live longer.
This collaboration may involve compensation for work performed, reimbursement for travel expenses, modest hospitality, a charitable donation, or a grant. These are considered “transfers of value.” They are not intended to influence anyone’s work. Rather, they represent fair market value compensation for work conducted by qualified professionals and institutions, reimbursement of reasonable expenses, and modest hospitality such as food while attending a meeting that occurs during normal meal hours. These transfers of value also might be a charitable donation or a grant intended to contribute to improved patient care.
We report these payments here. GSK was one of the first pharmaceutical companies to voluntarily disclose information about our work with physicians—in fact, we’ve reported the fees we’ve paid for speaking and consulting since 2009 and have reported payments to institutions and lead investigators for assisting with clinical research studies since 2010.
Our reporting is consistent with our company values to demonstrate openness, respect, integrity, and a clear focus on the best interests of patients in all that we do. These values guide us as we research, develop, manufacture, and promote our medicines and vaccines to the healthcare professionals and patients we serve.
For detail on the types of payments made and how we report them, see the About the Reports Section.